Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clayton

Showing results (541-550 of 569) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|May 5, 2007
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory painGerard M P Giblin, Celestine T O'Shaughnessy, Alan Naylor, et al.
Journal of the American College of Cardiology|March 30, 2002
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertensionRonald J Raymond, Alan L Hinderliter, Park W Willis, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2018
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP<sub>4</sub> receptor partial agonist for the treatment of painMark P Healy, Amanda C Allan, Kristin Bailey, et al.
BMJ Supportive & Palliative Care|May 27, 2026
Advance care planning in the Asia Pacific region: comparative implementation studyRaymond Ng Han Lip, Masanori Mori, Cheng-Pei Lin, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2010
Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic painJames W Myatt, Mark P Healy, Gianpaolo S Bravi, et al.
Implementation Science : IS|May 22, 2023
Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trialPhyllis Butow, Mona M Faris, Joanne Shaw, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Polyamine Metabolites as Biomarkers in Head and Neck Cancer BiofluidsBrian C DeFelice, Oliver Fiehn, Peter Belafsky, et al.
Brain : a Journal of Neurology|April 3, 2023
Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' conditionHelena Martins Custodio, Lisa M Clayton, Ravishankara Bellampalli, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
Pyridine-3-carboxamides as novel CB(2) agonists for analgesiaWilliam L Mitchell, Gerard M P Giblin, Alan Naylor, et al.
Pageof 57

Showing results (541-550 of 569) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|May 5, 2007
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory painGerard M P Giblin, Celestine T O'Shaughnessy, Alan Naylor, et al.
Journal of the American College of Cardiology|March 30, 2002
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertensionRonald J Raymond, Alan L Hinderliter, Park W Willis, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2018
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP<sub>4</sub> receptor partial agonist for the treatment of painMark P Healy, Amanda C Allan, Kristin Bailey, et al.
BMJ Supportive & Palliative Care|May 27, 2026
Advance care planning in the Asia Pacific region: comparative implementation studyRaymond Ng Han Lip, Masanori Mori, Cheng-Pei Lin, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2010
Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic painJames W Myatt, Mark P Healy, Gianpaolo S Bravi, et al.
Implementation Science : IS|May 22, 2023
Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trialPhyllis Butow, Mona M Faris, Joanne Shaw, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Polyamine Metabolites as Biomarkers in Head and Neck Cancer BiofluidsBrian C DeFelice, Oliver Fiehn, Peter Belafsky, et al.
Brain : a Journal of Neurology|April 3, 2023
Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' conditionHelena Martins Custodio, Lisa M Clayton, Ravishankara Bellampalli, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
Pyridine-3-carboxamides as novel CB(2) agonists for analgesiaWilliam L Mitchell, Gerard M P Giblin, Alan Naylor, et al.
Pageof 57